Hyperglycemia-induced inhibition of DJ-1 expression compromised the effectiveness of ischemic postconditioning

Min Liu1, Bin Zhou, Zhong-Yuan Xia

  • 1Department of Anesthesiology, Renmin Hospital of Wuhan University, 99 Zi Yang Road, Wuhan, Hubei 430060, China.

Insights

Ischemia postconditioning (IpostC) protects hearts from injury, but diabetes impairs this effect. Downregulation of DJ-1 in diabetic hearts may explain why IpostC fails to protect against myocardial ischemia reperfusion injury.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • Ischemia postconditioning (IpostC) effectively mitigates ischemia-reperfusion injury.
  • Diabetic mellitus impairs the cardioprotective efficacy of IpostC.
  • DJ-1, a protein with antioxidant properties, is investigated for its role in IpostC.

Purpose of the Study:

  • To investigate the role of DJ-1 in IpostC cardioprotection in a rat model of myocardial ischemia reperfusion injury.
  • To explore the impact of diabetes on DJ-1 expression and its relationship with IpostC efficacy.

Main Methods:

  • A rat model of myocardial ischemia reperfusion injury was utilized.
  • Cardiac DJ-1 levels were assessed in normal and diabetic rats.
  • The effects of IpostC on infarct size, oxidative stress, and PI3K/Akt signaling were evaluated.

Main Results:

  • Cardiac DJ-1 was downregulated in diabetic rats compared to normal rats.
  • IpostC reduced infarct size and oxidative stress in normal rats but not in diabetic rats.
  • DJ-1 levels increased post-ischemia and with IpostC in normal rats, but remained unchanged in diabetic rats.
  • PI3K/Akt signaling alterations may contribute to IpostC ineffectiveness in diabetes.
  • Positive correlation between p-Akt and DJ-1, and negative correlation between infarct size and DJ-1 were observed.

Conclusions:

  • DJ-1 plays a beneficial role in myocardial ischemia reperfusion.
  • Downregulation of cardiac DJ-1 in diabetes compromises the heart's responsiveness to IpostC cardioprotection.
  • Restoring DJ-1 levels may be a therapeutic strategy to improve IpostC efficacy in diabetic patients.